Thematic Investing Content Hub Biotech ETFs Jump: Keep an Eye on XBI, IBB & SBIO By Frank HolmanJune 18, 2019
Innovative ETFs Content Hub Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal By Max ChenJune 17, 2019
Relative Value Content Hub 12 Biggest Healthcare ETFs Ready for Sector Rebound By Tom LydonApril 24, 2019
Thematic Investing Content Hub Biotech ETFs: Destinations For Investing in Innovation By Brenton GarenApril 18, 2019
Innovative ETFs Content Hub Healthcare, Biotech ETFs Plunge on Mounting Political Pressures By Max ChenApril 18, 2019
Equity ETF Content Hub Tom Lydon on Yahoo Finance Live: SPY, Health Care, EM, and What to Avoid By Ben HernandezApril 16, 2019
Innovative ETFs Content Hub Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook By Max ChenMarch 6, 2019
Thematic Investing Content Hub Biotech ETFs Conquers an Important Technical Hurdle By Brenton GarenMarch 6, 2019
Core Equity Content Hub Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook By Max ChenJanuary 23, 2019
Leveraged & Inverse Content Hub Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat By Brenton GarenNovember 8, 2018
